Publicacións (21) Publicacións de Ines González Suarez

2024

  1. Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks

    Neurology, Vol. 103, Núm. 6

2023

  1. Alemtuzumab treatment in real clinical practice: Experience in a multicenter cohort.

    Multiple Sclerosis and Related Disorders, Vol. 75

  2. Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel

    Neurology and Therapy, Vol. 12, Núm. 2, pp. 427-439

  3. Real-world persistence to first-line DMTs in relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 78

  4. Reliability, validity and distribution of the Spanish female sexual function index in women with relapsing multiple sclerosis

    BMC Women's Health, Vol. 23, Núm. 1

  5. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  6. Teriflunomide and Epstein–Barr virus in a Spanish multiple sclerosis cohort: in vivo antiviral activity and clinical response

    Frontiers in Immunology, Vol. 14

2022

  1. Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology

    Frontiers in immunology, Vol. 13, pp. 842354

  2. Development of a scale for the evaluation of the quality of the shared decision process in multiple sclerosis patients

    PLoS ONE, Vol. 17, Núm. 5 May

  3. Impact of Neuromyelitis Optica Spectrum Disorder on Quality of Life from the Patients’ Perspective: An Observational Cross-Sectional Study

    Neurology and Therapy, Vol. 11, Núm. 3, pp. 1101-1116

2021

  1. Effect of Ocrelizumab in Blood Leukocytes of Patients With Primary Progressive MS

    Neurology(R) neuroimmunology & neuroinflammation, Vol. 8, Núm. 2

  2. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis

    Neurologia, Vol. 36, Núm. 6, pp. 403-411

  3. Para-infectious anti-GD2/GD3 IgM myelitis during the Covid-19 pandemic: Case report and literature review

    Multiple Sclerosis and Related Disorders, Vol. 49

  4. Quantifying the patient's perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire

    PLoS ONE, Vol. 16, Núm. 7 July

2017

  1. Catastrophic outcome of patients with a rebound after Natalizumab treatment discontinuation

    Brain and Behavior, Vol. 7, Núm. 4

  2. Inhibition of neurogenesis in a case of Marburg variant multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 18, pp. 71-76

  3. Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial

    Cephalalgia, Vol. 37, Núm. 9, pp. 864-872

2016

  1. Analysis of the relationship between the month of birth and risk of multiple sclerosis in a Spanish population

    European Neurology, Vol. 76, Núm. 5-6, pp. 202-209

2013

  1. Focalidad neurológica como primera manifestación de un mixoma cardiaco

    Neurologia

2012

  1. Intravenous thrombolysis in a 14 year old male with cerebral infarction due to dissection of the internal carotid artery

    Revista de Neurologia